Since CaMKs and CREB were also identified as potential proteins with reduced phosphorylation after CN03 treatment in the rd1 model [13], PKG-mediated CaMKs-CREB signaling appears to be a promising target to develop potential biomarkers for retinal disease progression and therapy response. The gene discussed is PDE6B; the disease is Abnormal retinal morphology.